InsidersTradesSigma
Track the EKF Diagnostics Holdings plc stock price and the full directors' dealings record of the company, a publicly traded company based in United Kingdom. Shares trade on the UK market, under the oversight of RNS (LSE). Market capitalisation: €110.5m. The latest transaction was filed on 26 March 2025 (Purchase). Among the most active insiders: Harwood Capital LLP and Harwood Capital Management (Gibraltar) Ltd, (the "Investment Managers"). All data is free.
Analysts rate EKF Diagnostics Holdings plc Strong Buy (bullish), based on 3 analysts. Average price target: £34.67.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
EKF Diagnostics Holdings plc es una empresa centrada en el desarrollo y la fabricación de dispositivos de diagnóstico médico. Se especializa en soluciones para medicina de laboratorio y atención sanitaria en el punto de atención.